Shopping Cart 0
Cart Subtotal
USD 0

Chembio Diagnostic Inc (CEMI) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers its products to medical laboratories and hospitals, non-governmental organizations, governmental and public health entities, medical professionals and retailers. The company distributes its products through a network of distributors worldwide. Chembio is headquartered in Medford, New York, the US.

Chembio Diagnostic Inc (CEMI)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Chembio Diagnostic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Chembio Diagnostic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Chembio Diagnostic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Chembio Diagnostic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Chembio Diagnostic Inc, Medical Equipment, Deal Details 12

Asset Purchase 12

Chembio Diagnostics Acquires Rights to SURE CHECK(R) HIV 1/2 Assay From StatSure Diagnostic Systems 12

Partnerships 13

Chembio Diagnostics Enters Into Licensing Agreement With RVR Diagnostics 13

Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 14

Chembio Diagnostic Enters into Agreement with Bio Manguinhos 15

Chembio Diagnostic Enters into Agreement with LumiraDx 16

Chembio Diagnostic Enters into Agreement with AstraZeneca 17

Chembio Diagnostics Enters into Agreement with FIND 18

Chembio Diagnostics Enters into Co-Development Agreement with Bio-Manguinhos 19

Chembio Diagnostics Enters into Agreement with Perseus Science 20

Chembio Diagnostics Enters into Co-Development Agreement with Integrated BioTherapeutics 21

Chembio Diagnostics Enters into Agreement to Develop POC Diagnostic Tests for Dengue Fever Virus and Specific Type of Cancer 22

Chembio Enters Into Distribution Agreement With Labtest For Dual Path Platform Products 23

Equity Offering 24

Chembio Diagnostic Plans to Raise USD50 Million in Public Offering of Securities 24

Chembio Diagnostics Raises USD12 Million in Public Offering of Shares 25

Chembio Diagnostics Raises USD13.8 Million in Public Offering of Shares 26

Chembio Diagnostics Completes Public Offering Of Common Stock For USD 6 Million 28

Acquisition 29

Chembio Diagnostics Acquires RVR Diagnostics 29

Chembio Diagnostic Inc-Key Competitors 30

Chembio Diagnostic Inc-Key Employees 31

Chembio Diagnostic Inc-Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 33

Financial Announcements 33

Aug 08, 2018: Chembio Diagnostics reports second quarter 2018 financial results 33

May 09, 2018: Chembio Diagnostics Reports First Quarter 2018 Financial Results 34

Mar 08, 2018: Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results 35

Nov 08, 2017: Chembio Diagnostics Reports Third Quarter 2017 Financial Results 36

Aug 09, 2017: Chembio Diagnostics Reports Second Quarter 2017 Financial Results 38

May 09, 2017: Chembio Diagnostics Reports First Quarter 2017 Financial Results 40

Mar 07, 2017: Chembio Diagnostics Reports 2016 Financial Results 42

Corporate Communications 44

Aug 08, 2018: Chembio Diagnostics appoints Dr. Mary Lake Polan to its board of directors 44

Jul 19, 2018: Chembio Diagnostics names Christine Rousseau as vice president, corporate development 45

May 16, 2018: Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors 46

Dec 20, 2017: Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer 47

Dec 20, 2017: Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer 48

Aug 17, 2017: Chembio Diagnostics Announces Retirement of Chief Financial Officer 49

Jul 06, 2017: Gail S. Page Joins Chembio Diagnostics Board of Directors 50

Jan 26, 2017: Chembio Appoints Sales Executives in Latin America, Africa, Asia Pacific 51

Other Significant Developments 52

Jul 28, 2018: FIND announces new wave of activities to address the challenges threatening hepatitis C elimination through potential diagnostic technologies 52

Sep 08, 2017: Ginolis Rapid Test Assembly System Selected by Chembio Diagnostics 53

Appendix 54

Methodology 54

About GlobalData 54

Contact Us 54

Disclaimer 54


List Of Figure

List of Figures

Chembio Diagnostic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Chembio Diagnostic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Chembio Diagnostic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Chembio Diagnostic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Chembio Diagnostic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Chembio Diagnostic Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Chembio Diagnostic Inc, Medical Equipment, Key Facts, 2017 2

Chembio Diagnostic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Chembio Diagnostic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Chembio Diagnostic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Chembio Diagnostic Inc, Deals By Market, 2012 to YTD 2018 9

Chembio Diagnostic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Chembio Diagnostics Acquires Rights to SURE CHECK(R) HIV 1/2 Assay From StatSure Diagnostic Systems 12

Chembio Diagnostics Enters Into Licensing Agreement With RVR Diagnostics 13

Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 14

Chembio Diagnostic Enters into Agreement with Bio Manguinhos 15

Chembio Diagnostic Enters into Agreement with LumiraDx 16

Chembio Diagnostic Enters into Agreement with AstraZeneca 17

Chembio Diagnostics Enters into Agreement with FIND 18

Chembio Diagnostics Enters into Co-Development Agreement with Bio-Manguinhos 19

Chembio Diagnostics Enters into Agreement with Perseus Science 20

Chembio Diagnostics Enters into Co-Development Agreement with Integrated BioTherapeutics 21

Chembio Diagnostics Enters into Agreement to Develop POC Diagnostic Tests for Dengue Fever Virus and Specific Type of Cancer 22

Chembio Enters Into Distribution Agreement With Labtest For Dual Path Platform Products 23

Chembio Diagnostic Plans to Raise USD50 Million in Public Offering of Securities 24

Chembio Diagnostics Raises USD12 Million in Public Offering of Shares 25

Chembio Diagnostics Raises USD13.8 Million in Public Offering of Shares 26

Chembio Diagnostics Completes Public Offering Of Common Stock For USD 6 Million 28

Chembio Diagnostics Acquires RVR Diagnostics 29

Chembio Diagnostic Inc, Key Competitors 30

Chembio Diagnostic Inc, Key Employees 31

Chembio Diagnostic Inc, Subsidiaries 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Chembio Diagnostic Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.